A new study has assessed the links between cholesterol and cognitive function.
Academic rigor, journalistic flair
Articles on Statins
Displaying 1 - 20 of 25 articles
Current cholesterol tests in the UK are outdated and are putting lives at risk.
Having very high levels of HDL is associated with increased mortality. But that doesn't mean it's not 'good cholesterol'.
An Australian trial will give us a clearer picture of whether healthy old people benefit from taking statins to prevent heart disease and stroke.
Using electronic medical records may be a better way to treat those at risk of heart disease than treating everyone or treating only known 'at risk' groups.
Misreporting on the ongoing debate is likely to lead to more deaths from cardiovascular disease.
Rare diseases are yielding secrets about very common conditions.
Even for those on statins, a healthy Mediterranean eating pattern has been shown to bring extra benefits.
Fewer than half of Australians who have had a heart attack take blood pressure and cholesterol-lowering drugs to prevent them having another one.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
Lipitor was approved by the government in 1997, and while under patent protection it was the highest-selling drug of all time with worldwide sales of more than US$12 billion a year.
While studies suggests that cholesterol-lowering statins can make the flu shot less effective, the vaccine remains the best available tool for reducing flu-related complications and death.
Media are important. Especially the media we trust. One might express the effect of a piece of journalism (J) about, say, a particular drug or food, as a factor of media authority (A), multiplied by the…
In October 2013, Catalyst broadcast a segment highly critical of statins, a class of drug used for lowering cholesterol.
Apart from proposing a co-payment for visiting doctors, the last federal budget also contained a proposal to increase the level of co-payments for medications. The government seems to have given little…
A panel convened by medical journal BMJ to investigate whether it was right to correct rather than retract two pieces featuring a mistake about side effects from statins has endorsed the journal’s decision…
The recent retraction of an academic claim in a leading journal about the incidence of side effects from cholesterol-lowering drugs has sparked anger in the medical community and potentially undermined…
What we know about statins comes almost entirely from commercial interests. So what we take for knowledge about their harms and benefits is actually information designed to optimise the drug makers’ responsibility…
Nearly 13m more adults in the US will be eligible for statins after new guidelines widened the criteria for use of the drugs…
A by-product of cholesterol has been found to enhance the growth and spread of the most common types of breast cancer. Mimicking…
Top contributors
-
Professor of Clinical Epidemiology, Bond University
-
Professor of Health Economics, University of Melbourne
-
Lecturer on Health Care Policy, Harvard University
-
Senior Lecturer in Biology and Biomedical Science, Aston University
-
Professor of Journalism, Media and Communication, Queensland University of Technology
-
Senior lecturer in Pharmacology, University of Adelaide
-
Emeritus Professor in Public Health, University of Sydney
-
Nutritionist & Visiting Fellow, UNSW
-
Professor of Medicine, Bond University
-
Nial Wheate is a Friend of The Conversation.
Associate Professor | Program Director, Undergraduate Pharmacy, University of Sydney
-
Professor of Medicine, Pharmacology and Bioengineering, University of Illinois at Chicago
-
Professor of Internal Medicine and Preventative Cardiology, Griffith University
-
Senior Lecturer, School of Medicine, Griffith University
-
Research Fellow, University of Sydney
-
Professor of Biostatistics, Duke University
